Financials in USD. Standardized financial statements.
A compact view of how Carl Zeiss Meditec AG turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.23B | $2.07B | $2.09B | $1.90B | $1.65B | $1.34B | $1.46B | $1.28B | $1.19B | $1.09B |
| Revenue Growth? | +7.8% | -1.1% | +9.8% | +15.5% | +23.3% | -8.5% | +13.9% | +7.6% | +9.3% | 0.0% |
| Cost of Revenue? | $1.05B | $977.50M | $883.53M | $775.24M | $679.57M | $589.93M | $627.44M | $570.47M | $533.16M | $508.82M |
| Gross Profit? | $1.18B | $1.09B | $1.21B | $1.13B | $967.21M | $745.52M | $831.88M | $710.39M | $656.73M | $579.55M |
| Gross Margin? | +52.8% | +52.7% | +57.7% | +59.3% | +58.7% | +55.8% | +57.0% | +55.5% | +55.2% | +53.2% |
| Operating Expenses? | $951.88M | $967.28M | $878.63M | $730.72M | $616.30M | $586.17M | $579.38M | $520.73M | $484.43M | $425.21M |
| Operating Income? | $223.32M | $121.35M | $327.14M | $396.88M | $350.91M | $159.35M | $252.50M | $197.13M | $172.30M | $146.37M |
| EBITDA? | $407.00M | $225.05M | $501.88M | $482.85M | $410.00M | $267.03M | $286.44M | $213.12M | $206.96M | $165.78M |
| Income Before Tax | $193.89M | $240.87M | $412.56M | $403.49M | $339.05M | $178.72M | $229.86M | $179.18M | $188.56M | $141.96M |
| Income Tax Expense | $51.55M | $60.71M | $120.56M | $107.58M | $101.53M | $55.30M | $69.28M | $52.95M | $52.78M | $41.99M |
| Net Income? | $141.21M | $178.73M | $290.40M | $293.91M | $236.28M | $122.39M | $159.76M | $126.46M | $134.44M | $98.33M |
| EPS? | $1.61 | $2.01 | $3.25 | $3.29 | $2.64 | $1.37 | $1.79 | $1.41 | $1.57 | $1.21 |
| Diluted EPS? | $1.61 | $2.01 | $3.25 | $3.29 | $2.64 | $1.37 | $1.79 | $1.41 | $1.57 | $1.21 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality